Document:

Exhibit 10.8

 

THIS SECURITY HAS
NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION
FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, IT MAY NOT
BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE BORROWER. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY
SUCH SECURITIES.

 

SENIOR
SECURED PROMISSORY NOTE

 

DUE
OCTOBER 5, 2023

 

	Original Issue Date: October 5, 2022	 	Principal Amount:     $[●]
	 	 	 
	 	 	Purchase
Price           $[●]

 

This Senior
Secured Promissory Note is one of a series of duly authorized and validly issued Secured Notes of ____________________________
(together with its successors and permitted assigns, the “Company”), designated as its Senior Secured Promissory
Note due October 5, 2023 (this “Note” and, collectively with the other Notes of such series, the
 “Notes”), issued and sold by the Company pursuant to the Securities Purchase Agreement, dated as of
October 5, 2022, among the Digital Health Acquisition Corp. (“Company”), VSee
Lab, Inc.(“VSee”), and iDoc Virtual Telehealth Solutions, Inc.
(“iDoc”) (collectively, the “Sellers”) and ________________________ and the other
purchasers listed therein; ______________________ (together with its successors and registered assigns, the
 “Holder” or the “Purchaser”) (the “Purchase Agreement”).

 

The
Company, VSee, and iDoc seek to consummate the Business Combination in accordance with the terms and conditions of the Business Combination
Agreement. In connection with consummation of the Business Combination and thereafter, they each need working capital and are seeking
bridge financing. To this end, the Company, VSee, and iDoc as the Sellers have entered into the Purchase Agreement, concerning, among
other matters, the issuances and sales of certain notes to the Holder.

 

FOR
VALUE RECEIVED, the Company promises to pay to the order of Holder, the principal amount of
Eight Hundred Eighty-Eight Thousand, Eight Hundred Eighty-Eight Dollars and Eighty Cents ($888,888.80) on October 5, 2023 (the “Maturity
Date”) in full in cash as provided herein or in any other Transaction Documents, or on such earlier date as this Note is required
or permitted to be repaid as provided hereunder, in each case together with all accrued but unpaid interest thereon (including any Minimum
Interest Amount remaining on such principal amount as of such date),and any other amounts owing under this Note or any other Transaction
Document in accordance with the provisions hereof. Amounts repaid may not be reborrowed. The Holder may set off and deduct pursuant to
and in accordance with the Transaction Documents amounts due to the Holder or the Purchaser Parties.

 

This
Note is subject to the following additional provisions:

 

SECTION 1.     Definitions

 

Capitalized
terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the
Purchase Agreement. In addition, for the purposes hereof, the following terms shall have the following meanings:

 

“Amortization
Payment” shall have the meaning set forth in Section 2(a).

 

    	 	1	 

     

    

 

“Amortization
Payment Date” shall have the meaning set forth in Section 2(a).

 

“Business
Combination” means the consummation of the proposed business combination in accordance with the terms and conditions set forth
in that certain Second Amended and Restated Business Combination Agreement
dated October 5, 2022, by and among the Company, DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee
Lab, Inc., and iDoc Virtual Telehealth Solutions, Inc. (the “Business Combination
Agreement”), as further described in the Company’s Current Report on Form 8-K, which was filed with the Commission
on August 11, 2022.

 

“Capital
Lease” means, as applied to any Person, any lease of, or other arrangement conveying the right to use, any property (whether
real, personal or mixed) by that Person as lessee that, in conformity with U.S. generally accepted accounting principles (GAAP) consistently
applied, is or should be accounted for as a capital lease on the balance sheet of that Person.

 

“Capital
Stock” means any share, participation or other equivalent (however designated) of the capital stock of a corporation, any equivalent
ownership interest in any other Person, including partnership interests and membership interests, and any warrant, right or option to
purchase or other arrangement (including through a conversion or exchange of any other property) to acquire or subscribe for any item
otherwise satisfying the definition of “Capital Stock,” whether or not presently convertible, exchangeable or exercisable.

 

“Change
of Control Transaction” means, other than the consummation of the Business Combination and then only on terms and conditions,
and using documentation, acceptable to the Holder, the occurrence after the date hereof of any of (a) an acquisition after the date
hereof by an Person or “group” (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective
control (whether through legal or beneficial ownership of capital stock of the Company, by contract or otherwise) of in excess of fifty
percent (50%) of the voting Capital Stock (or Stock Equivalents) of the Company (other than by means of exercise of the Warrants and
the issuance of the Warrant Shares (as such term is defined in the Warrant) thereunder); (b) the Company merges into or consolidates
with any other Person, or any Person merges into or consolidates with the Company and, after giving effect to such transaction, the stockholders
of the Company immediately prior to such transaction own less than fifty percent (50%) of the aggregate voting power of the Company or
the successor entity of such transaction; (c) the Company sells or transfers all or substantially all of its assets to another Person
and the stockholders of the Company immediately prior to such transaction own less than fifty percent (50%) of the aggregate voting power
of the acquiring entity immediately after the transaction; (d) during any period of twelve consecutive calendar months, individuals
who at the beginning of such period constituted the board of directors of the Company (together with any new directors whose election
by the board of directors of the Company or whose nomination for election by the stockholders of the Company was approved by a vote of
a majority of the directors then still in office who either were directors at the beginning of such period or whose elections or nomination
for election was previously so approved) cease for any reason other than death or disability to constitute a majority of the directors
then in office; or (e) the execution by the Company of an agreement to which the Company is a party or by which it is bound, providing
for any of the events set forth in clauses (a) through (d) above.

 

“Common
Stock” means the common stock of the Company, par value $0.0001 per share, and any other Capital Stock into which such shares
of common stock may hereafter be changed or any share capital resulting from a reclassification of such common stock.

 

“Contractual
Obligation” means, with respect to any Person, any provision of any Security issued by such Person or of any agreement, undertaking,
contract, lease, indenture, mortgage, deed of trust or other instrument (other than a Transaction Document) to which such Person is a
party or by which it or any of its property is bound or to which any of its property is subject.

 

“Customary
Permitted Liens” means all of the following:

 

(i)            Liens
securing the payment of taxes, assessments or other charges or levies imposed by any Governmental Authority which are either not yet
overdue or the validity of which are being contested in good faith by appropriate proceedings diligently pursued and with respect to
which adequate reserves have been set aside on its books;

 

    	 	2	 

     

    

 

(ii)            non-consensual
statutory Liens (other than Liens securing the payment of taxes) arising in the ordinary course of business to the extent (A) such
Liens secure Indebtedness that is not overdue for a period of more than 30 days or (B) such Liens secure Indebtedness relating to
claims or liabilities that are fully insured and being defended at the sole cost and expense and at the sole risk of the insurer or being
contested in good faith by appropriate proceedings diligently pursued, in each case prior to the commencement of foreclosure or other
similar proceedings and with respect to which adequate reserves have been set aside on its books;

 

(iii)            zoning,
building and land use restrictions, easements, servitudes, encumbrances, licenses, covenants and other restrictions affecting the use
of real property or minor defects or irregularities in title thereto that do not interfere in any material respect with the use of such
real property or the ordinary conduct of the business of the Company and its Subsidiaries as presently conducted thereon or materially
impair the value of the real property that may be subject thereto;

 

(iv)            pledges
and deposits of cash in the ordinary course of business in connection with workers’ compensation, unemployment insurance and other
types of social security benefits consistent with current practices as in effect on the date hereof;

 

(v)            undetermined
or inchoate Liens and charges arising or potentially arising under statutory provisions which have not at the time been filed or registered
in accordance with applicable Law or of which written notice has not been duly given in accordance with applicable Regulation or which
although filed or registered, relate to obligations not due or delinquent, including without limitation statutory Liens incurred, or
pledges or deposits made, under worker’s compensation, employment insurance and other social security legislation;

 

(vi)           Liens
or deposits to secure the performance of bids, tenders, expropriation proceedings, trade contracts, leases, statutory obligations, surety
and performance bonds and other obligations of a like nature (other than for borrowed money), and deposits to secure equipment contracts,
in each case incurred in the ordinary course of business;

 

(vii)          appeal
bonds;

 

(viii)         landlord
Liens for rent not yet due and payable;

 

(ix)            Liens
arising from operating leases and the precautionary UCC financing statement filings in respect thereof;

 

(x)             judgments
and other similar Liens arising in connection with court proceedings that do not constitute an Event of Default; provided, that, (A) such
Liens are being contested in good faith and by appropriate proceedings diligently pursued, (B) adequate reserves or other appropriate
provision, if any, as are required by U.S. GAAP, consistently applied, have been made therefor and (C) a stay of enforcement of
any such Liens is in effect; and

 

(xi)            customary
rights of set-off or combination of accounts in favor of a financial institution with respect to deposits maintained by it.

 

“Default
Interest” means twenty-four percent (24%) per annum.

 

“Exempt
Issuance” means the issuance of (a) securities further to the PIPE, (b) shares
of Common Stock or options to employees, officers, directors, advisors or independent contractors of the Company; provided, that
such issuance is approved by a majority of the board of directors of the Company or stockholders of the Company, or as part of a bona
fide equity finance round,; and provided, further that such issuance shall not exceed in the aggregate 15% of the outstanding
shares of Common Stock as of the date hereof without the prior approval of the Purchaser, (c) shares of Common Stock, warrants or
options to advisors or independent contractors of the Company for compensatory purposes, (d) Conversion Shares or Warrant Shares
and other Securities issued upon the exercise or exchange of or conversion of any Notes or Warrants issued pursuant to the Purchase Agreement
and/or other Securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date
hereof; provided, that such securities have not been amended since the date hereof to increase the number of such securities or
to decrease the exercise price, exchange price or conversion price of such securities, (e) securities issuable pursuant to any contractual
anti-dilution obligations of the Company in effect as of the date hereof; provided, that such obligations have not been materially
amended since the date of hereof, and (f) Securities issued pursuant to acquisitions or any other strategic transactions, including,
without limitation, the Business Combination, approved by a majority of the disinterested members of the Board of Directors; provided,
that any such issuance shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising
capital or to an entity whose primary business is investing in securities.

 

    	 	3	 

     

    

 

“Event
of Default” shall have the meaning set forth in Section 5(a).

 

“Fundamental
Transaction” means, other than the consummation of the Business Combination and then only on terms and conditions, and using
documentation, acceptable to the Holder, any of the following transactions, whether effected directly or indirectly or through on or
a series of related transactions: (i) any merger or consolidation of the Company with or into another Person; (ii) any sale,
lease, license, assignment, transfer, conveyance or other disposition of all or more than 10% of the Company’s assets, (iii) the
completion and acceptance by holders of more than 50% of the Common Stock of any purchase offer, tender offer or exchange offer (whether
by the Company or another Person) pursuant to which holders of Common Stock sell, tender or exchange their shares for other Securities,
cash or property, (iv) any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange
pursuant to which the Common Stock is effectively converted into or exchanged for other Securities, cash or property, (v) a stock
or share purchase or other business combination (including a reorganization, recapitalization, spin-off or scheme of arrangement) whereby
any other Person acquires more than fifty percent (50%) of the outstanding shares of Common Stock (not including any shares of Common
Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party
to, such stock or share purchase or other business combination).

 

“Late
Fee” shall have the meaning set forth in Section 2(e)

 

“Make
Whole Amount” means each of the Mandatory Default Amount and the Minimum Interest Amount.

 

“Mandatory
Default Amount” means, at any time, the sum of (a) one hundred twenty-five percent (125%) of the sum of the outstanding
principal amount of this Note at such time all accrued interest hereon unpaid at such time (whether or not accruing after the filing
of any petition in bankruptcy, or the commencement of any insolvency, reorganization or similar proceeding, whether or not a claim for
post-filing or post-petition interest is allowed in such proceeding, and including any Minimum Interest Amount remaining outstanding
on such principal amount as of such time) and (b) all other amounts, costs, fees (including Late Fees), expenses, indemnification
and liquidated and other damages and other Obligations due to the Holder or any other Purchaser Party in respect of this Note or any
other Transaction Document.

 

“Mandatory
Prepayment Amount” means, at any time with respect to any principal amount, the sum of (a) one hundred percent (100%)
of such principal amount and all accrued interest hereon outstanding as of such time (including any Minimum Interest Amount remaining
outstanding on such principal amount as of such time) and (b) all other amounts, costs, fees (including Late Fees), expenses, indemnification
and liquidated and other damages and other amounts due to the Holder or any other Purchaser Party in respect of this Note or any other
Transaction Document.

 

“Minimum
Interest Amount” means, on any date and with respect to any principal amount owing under this Note, the difference between
(a) 10% of such principal amount, representing a full year of interest payments hereunder and (b) any payment of interest made
prior to such date with respect to such principal amount. The Minimum Interest Amount is not meant as a penalty but rather is meant to
cover Holder’s transaction costs incurred in connection with its analysis of this investment as well as the costs associated with
the negotiation and consummation of the transactions contemplated by the Transaction Documents, Holder’s opportunity costs, and
Holder’s minimum anticipated profit.

 

“Note
Register” shall have the meaning specified in Section 2(f).

 

    	 	4	 

     

    

 

“Obligations”
means all amounts, indebtedness, obligations, liabilities, covenants and duties of every type and description owing by any Company Party
from time to time to the Holder or its Purchaser Parties under this Note, the Warrants, or any other Transaction Document, whether direct
or indirect, joint or several, absolute or contingent, due or to become due, liquidated or unliquidated, secured or unsecured, now existing
or hereafter arising and however acquired (regardless of whether acquired by assignment), whether or not evidenced by any note or other
instrument or for the payment of money, including, without duplication, (i) the principal amount of the Note owing by the Company
or any other Company Party (including, if due hereunder, the Mandatory Default Amount or any Mandatory Prepayment Amount), (ii) all
other amounts, fees (including all Late Fees), interest (including the Minimum Interest Amount and any increased interest accruing upon
an Event of Default), liquidated damages, commissions, charges, costs, expenses, attorneys’ fees and disbursements, indemnities
(including Losses and other amounts for which any Company Party is required to indemnify the Holder or any of its Purchaser Parties under
the Purchase Agreement), reimbursement of amounts paid and other sums chargeable to any Company Party under any Transaction Document
or otherwise arising under any Transaction Document and (iii) all interest on any item otherwise qualifying as “Obligation”
hereunder, whether or not accruing after the filing of any petition in bankruptcy, or the commencement of any insolvency, reorganization
or similar proceeding, whether or not a claim for post-filing or post-petition interest is allowed in such proceeding.

 

“Original
Issue Date” means the date of the first issuance of this Note, regardless of any transfers of any Note and regardless of the
number of instruments which may be issued to evidence such Note.

 

“Permitted
Debt” means all of the following: (i) Indebtedness owing to any Secured Party (as defined in the Security Agreement) under
any Transaction Document; (ii) unsecured intercompany Indebtedness between the Company and any of its Subsidiaries in the ordinary
course of business; (iii) unsecured Indebtedness of the Company or any of its Subsidiaries to trade creditors (including overdue
amounts on invoices) incurred on customary terms in the ordinary course of business; (vi) Indebtedness of the Company or any Subsidiary
under Capital Leases for equipment or Indebtedness of the Company or any Subsidiary secured by a Purchase Money Lien, which Indebtedness
shall not at any time exceed $100,000 in the aggregate for the Company and its Subsidiaries; (vii) Indebtedness incurred in connection
with the PIPE; and (viii) Indebtedness of the Company or any of its Subsidiaries under leases for facilities that are treated as
Capital Leases under U.S. GAAP.

 

“Permitted
Liens” means (i) the security interests of the Secured Parties (as defined in the Security Agreement) as provided for
in any Transaction Document; (ii) Customary Permitted Liens; (iii) Purchase Money Liens granted to or held by Purchase Money
Lien lenders in connection with the purchase, leasing or acquisition of capital equipment in the ordinary course of business and without
resulting in a contravention of any applicable provisions of this Note or any other Transaction Document; and (iv) any Lien incurred
in connection with any Permitted Debt.

 

“PIPE”
means that proposed offering of up to $10.0 million of securities to be issued to 3i LP and other
institutional investors further to a proposed securities purchase agreement, said financing to be closed immediately after the closing
of the Business Combination, upon such terms and subject to such conditions that are satisfactory to Holder with respect to the Company’s
payment obligations to Holder.

 

“Purchase
Money Lien” means any Lien securing Indebtedness (i) upon or in any equipment acquired or held by the Company or any of
its Subsidiaries to secure the purchase price of such equipment or indebtedness incurred solely for the purpose of financing the acquisition
or lease of such equipment or (ii) existing on such equipment at the time of its acquisition, in each case provided, that the Lien
is confined solely to the property so acquired and improvements thereon, and the proceeds of such equipment.

 

“Repayment
Notice” shall have the meaning set forth in Section 2(a).

 

“Secured
Parties” means the Holder and each other holder of the Notes, each beneficiary of any indemnification or reimbursement obligation
by any Company Party under Purchase Agreement.

 

“Securities”
means any Capital Stock, voting trust certificates, certificates of interest or participation in any profit sharing Contractual Obligation
or arrangement, loans, bonds, debentures, notes, or other evidences of indebtedness, secured or unsecured, convertible, subordinated
or otherwise, any other item commonly known as “security,” any other item treated as “security” under the Securities
Act, the Investment Company Act of 1940, the Investment Advisers Act of 1940 or any other Regulation of the United States, any State,
province or any political subdivision of either of them and any certificate of interest, share or participation in temporary or interim
certificates for the purchase or acquisition of, or any option, warrant, right to subscribe to, purchase or acquire, or any Derivative
valued by reference to, any item otherwise qualifying as Security hereunder.

 

    	 	5	 

     

    

 

“Variable
Rate Transaction” means any transaction by the Company other than the PIPE, directly or indirectly, to (i)(A) consummate
any exchange of any Indebtedness and/or Securities of the Company for any other Securities and/or Indebtedness of the Company, (B) cooperate
with any person to effect any exchange of Securities and/or Indebtedness of the Company in connection with a proposed sale of such Securities
from an existing holder of such Securities to any other unrelated Person), and/or (C) reduce and/or otherwise change the exercise
price, conversion price and/or exchange price of any Stock Equivalent of the Company and/or amend any non-convertible Indebtedness of
the Company to make it convertible into Securities of the Company, (ii) issue or sell any of its Securities either (A) at a
conversion, exercise or exchange rate or price that is based upon and/or varies with the trading prices of, or quotations for, Common
Stock, and/or (B) with a conversion, exercise or exchange rate and/or price that is subject to being reset on one or more occasions
either (1) at some future date after the initial issuance of such Securities or (2) upon the occurrence of specified or contingent
events directly or indirectly related to the business of the Company or the market for the Common Stock, and/or (iii) enter into
any agreement (including an “equity line of credit” or an “at-the-market offering”) whereby the Company may sell
Securities at a future determined price. A “Variable Rate Transaction” shall also mean, collectively, an Equity Line
of Credit or similar agreement, or a Variable Priced Equity Linked Instrument. For purposes hereof, “Equity Line of Credit”
means any transaction involving a written agreement between the Company and an investor or underwriter whereby the Company has the right
to “put” securities of the Company or any Subsidiary to the investor or underwriter over an agreed period of time and at
future determined price or price formula (other than customary “preemptive” or “participation” rights or “weighted
average” or “full-ratchet” anti-dilution provisions or in connection with fixed-price rights offerings and similar
transactions that are not Variable Priced Equity Linked Instruments), and “Variable Priced Equity Linked Instruments”
means: (A) any Stock Equivalent convertible into, exercisable or exchangeable for, or carry the right to receive additional shares
of Common Stock either (1) at any conversion, exercise or exchange rate or other price that is based upon and/or varies with the
trading prices of or quotations for Common Stock at any time after the initial issuance of such Stock Equivalent, or (2) with a
conversion, exercise or exchange price that is subject to being reset on more than one occasion at some future date at any time after
the initial issuance of such debt or equity security due to a change in the market price of the Common Stock since date of initial issuance
(other than customary “preemptive” or “participation” rights or “weighted average” or “full-ratchet”
anti-dilution provisions or in connection with fixed-price rights offerings and similar transactions), and (B) any amortizing convertible
Stock Equivalent which amortizes prior to its maturity date, where the Company is required or has the option to (or any investor in such
transaction has the option to require the Company to) make such amortization payments in shares of Common Stock which are valued at a
price that is based upon and/or varies with the trading prices of or quotations for Common Stock at any time after the initial issuance
of such Stock Equivalent (whether or not such payments in stock are subject to certain equity conditions).

 

SECTION 2.     REPAYMENT

 

(a)            Repayment
upon the Consummation of the Business Combination. If this Note has not otherwise been paid off in full in accordance with Section 2(b) below,
commencing upon the closing of the Business Combination under the Business Combination Agreement, Holder at its option, may, upon five
Business Days’ prior written notice to the Company (the “Repayment Notice”), require the Company to pay off
and otherwise satisfy in full its Obligations under this Note (inclusive of the payment of the Make Whole Amount and any other amount
due hereunder). Subject to the prior sentence, if the Repayment Notice is delivered to the Company (i) by no later than ninety (90)
days from the Original Issue Date, then the repayment amount shall be the Mandatory Prepayment Amount and (ii) after ninety (90)
days from the Original Issue Date, then the repayment amount shall be one hundred and ten percent (110%) of the Mandatory Prepayment
Amount.

 

(b)            Mandatory
Prepayments. Upon the closing of the Business Combination under the Business Combination Agreement and if the PIPE closes in connection
therewith, the Company shall repay the Note in its entirety (inclusive of the payment of the Make Whole Amount and any other amount due
hereunder) by the payment to the Holder in immediately available Dollars an amount equal to the Mandatory Prepayment Amount. If this
Note has not otherwise been paid off in full in accordance with the preceding sentence or otherwise, so long as a majority of the original
aggregate principal amount of the Notes remains outstanding on the date of any Subsequent Offering (as defined below), on the 10th
day following the Company consummating any public or private offering of any Capital Stock or any other issuance of any Capital
Stock or of any other Securities or any other financing, including any debt financing, or capital-raising transaction of any kind (each
a “Subsequent Offering”) on any date other than the Maturity Date, in which the Company receives or is otherwise entitled
to receive (except for the Company directing that such proceeds be paid to other Persons), the Company shall, subject to the Holder’s
conversion rights set forth herein, pay to the Holder in immediately available Dollars an amount equal to the Mandatory Prepayment Amount.
The Company shall provide notice to the Holder of the closing of such Subsequent Offering, including the expected gross proceeds thereof,
not later than the 10th day preceding the date of consummation of such Subsequent Offering, which notice shall be irrevocable
and constitute an agreement to pay the Mandatory Prepayment Amount on the date of consummation of such Subsequent Offering. The Holder
may continue to convert the principal amounts to be prepaid under this Note until the date of consummation of such Subsequent Offering;
provided, that, if the Company does not provide such notice, in addition to all other remedies provided under the Transaction
Documents for failure to comply with this Note, the Holder may refuse such payment in whole or in part and convert the Note in the amount
of such payment refused and, in its sole discretion, apply such payment to other outstanding Obligations, if any. This Section 2(b) is
merely a requirement to redeem this Note and not an authorization to consummate any Subsequent Offering otherwise prohibited by the Transaction
Documents.

 

    	 	6	 

     

    

 

(c)            Company
Call. [Reserved].

 

(d)            Interest.
The Company shall pay interest to the Holder on the aggregate then outstanding principal amount of this Note and any other Obligation
owing that does not expressly provide for any other rate of interest at the rate of ten percent (10%) per annum from the date this Note
is issued (or in the case of any other Obligation, from the date such obligation becomes due and payable) until all such principal amount
and all other outstanding Obligations are paid in full in cash in immediately available Dollars (including all accrued and unpaid interest,
liquidated damages and other amounts which may become due under any Transaction Document). All interest payments hereunder will be payable
in cash, in immediately available Dollars Upon an Event of Default, the interest rate set forth hereunder shall increase as provided
in Section 5(b) of this Note. All payments of interest shall be due and payable upon each amortization payment date;
monthly on the first Business Day of each month, upon the occurrence and continuation of an Event of Default; on the Maturity Date, and
shall reduce the Minimum Interest Amount, and any remaining Minimum Interest Amount shall be due and payable the early repayment of principal
as provided hereunder to compensate the Holder for a lesser profit in case of early repayment and for the internal and external work
and expenditure of time and money involved in the evaluation, preparation and closing of the Transaction Documents. The Minimum Interest
Amount is not to be construed to cover or be applied against any indemnity or any out-of-pocket fees, costs or expenses incurred in any
action to collect any Obligation or to foreclose any Lien securing the same. This provision shall not affect or limit the holder’s
rights or remedies with respect to any Event of Default.

 

(e)            Late
Fee. The Company shall pay a late fee (the “Late Fees”) on any Obligation required to be paid under this Note
or any other Transaction Document and not paid within five (5) Business Days when due, at an amount equal to the lesser of ten percent
(10%) of such Obligation or the maximum amount permitted by applicable law, in cash. These Late Fees are to cover the extra internal
expenses and inconvenience involved in handling delinquent payments and is not to be construed to cover or be applied against any indemnity
or any out-of-pocket fees, costs or expenses incurred in any action to collect any Obligation or to foreclose any Lien securing the same.
This provision shall not affect or limit the Holder’s rights or remedies with respect to any Event of Default.

 

(f)             Fee
Calculations and Payment Provisions. All payments made under any Transaction Document, except as otherwise expressly provided herein
or in such other Transaction Document, shall be made in cash, in immediately available U.S. dollars, without set off or counterclaim
to the Person in whose name this Note is registered on the records of the Company regarding registration and transfers of this Note (the
 “Note Register”). Any interest and fees shall be calculated on the basis of a 360-day year, consisting of twelve (12)
thirty (30) calendar day periods, for the actual number of days (including the first day but excluding the last day) occurring in the
applicable period and shall accrue daily provided, that the Minimum Interest Amount shall be deemed to be fully earned and accrued
on the Original Issue Date and payable as provided in this Agreement. Interest hereunder will be paid to the initial Holder or, if the
Company has received notice of any transfer thereof signed by the initial Holder or any successive Holders, to the Person in whose name
this Note is registered on the records of the Company regarding registration and transfers of this Note (the “Note Register”).
No prepayment may be made hereunder without the notice required hereunder or without payment of the Mandatory Prepayment Amount. The
Holder shall have the option to refuse or accept, in its sole discretion, any attempted prepayment made without the notice required hereunder
or any attempted prepayment that does not appear to include the full Mandatory Prepayment Amount when required. In addition, regardless
of the intended characterization of the Company of any payment, the Holder shall have the option, in its sole discretion, to recharacterize
or apply any portion of such prepayment, including recharacterizing a payment as a smaller prepayment of principal together with payment
of the remainder of the Mandatory Prepayment Amount to account for a payment of the Mandatory Prepayment Amount. The Holder may apply
any payment made under any Transaction Document to any outstanding Obligation, in its sole discretion. The Company hereby irrevocably
waives the right to direct the application of any payment in respect to any Obligation due under the Transaction Documents including,
after any Event of Default, any proceeds of Collateral thereunder. Whenever any payment hereunder shall be stated to be due on a day
other than a Business Day, the due date for such payment shall be extended to the next succeeding Business Day, and such extension of
time shall in such case be included in the computation of payment of any interest or fees, as the case may be. Each determination by
the Holder of an amount of interest or fee due under any Transaction Document shall be conclusive and binding for all purposes, absent
manifest error.

 

    	 	7	 

     

    

 

SECTION 3.     TRANSFERs

 

This
Note and any of the rights granted hereunder are freely transferable or assigned by Holder, in whole or in part, in its sole discretion.
The parties to such transfer shall provide notice thereof to the Company. This Note is exchangeable for an equal aggregate principal
amount of Notes of different authorized denominations, as requested by the Holder surrendering the same. No service charge will be payable
for such registration of transfer or exchange. This Note has been issued subject to certain investment representations of the original
Holder and may be transferred or exchanged only in compliance with applicable federal and state securities regulations. The initial Holder
is listed herein. Prior to due presentment for transfer to the Company of this Note, the Company and any agent of the Company may treat
the Person in whose name this Note is duly registered, upon receipt of appropriate signed notice from the Person previously listed on
the Note Register as owner hereof, on the Note Register as the owner hereof for the purpose of receiving payment as herein provided and
for all other purposes, whether or not this Note is overdue, and neither the Company nor any such agent shall be affected by notice to
the contrary.

 

SECTION 4.     NEGATIVE
COVENANTS

 

(a)            As
long as any portion of this Note or any other Obligation is not paid in full in cash, the Company shall not, and shall not permit any
of its Subsidiaries to, directly or indirectly, do, or enter into any agreement to do, any of the following:

 

i.            create,
enter into, create, incur, assume, enter into Guaranty Obligations with respect to, or suffer to exist any Indebtedness (other than Permitted
Debt) or repay the principal amount of, redeem, purchase or otherwise acquire or offer to repay the principal amount of, redeem, repurchase
or otherwise acquire any Indebtedness (other than Permitted Debt) whether or not existing on the Original Issue Date (other than the
Notes on a pro rata basis based on the principal amounts outstanding);

 

ii.            create,
permit, incur or suffer to exist any Lien of any kind, on or with respect to any of its assets now owned or hereafter acquired or any
interest therein or any income or profits therefrom, other than the Liens securing the Obligations created pursuant to the Transactions
Documents and Permitted Liens;

 

iii.            sell
or otherwise dispose of any of its assets other than disposition of assets in the ordinary course of business;

 

iv.            amend
its charter documents in any manner that materially and adversely affects any rights of the Holder;

 

v.            make,
approve, or offer to make any Restricted Payment with respect to any shares of Capital Stock;

 

    	 	8	 

     

    

 

vi.           enter
into any transaction with any Affiliate of the Company which would be required to be disclosed in any public filing with the Commission,
unless such transaction is made on an arm’s-length basis and expressly approved by a majority of the disinterested directors of
the Company (even if less than a quorum otherwise required for board approval);

 

vii.          consummate
a Change of Control Transaction or Fundamental Transaction other than the Business Combination and then only on terms and conditions,
and using documentation, acceptable to the Holder;

 

viii.          change
the nature of the Company’s business from the business conducted by the Company and its Subsidiaries on the date hereof (and, after
the consummation of the Business Combination, the business conducted by the targets of the Business Combination on the date hereof);

 

ix.            fail
to use the proceeds of the Note as provided for in the Transaction Documents, including being engaged in operations involving the financing
of any investments or activities in, or any payments to, any Sanctioned Person;

 

x.             directly
or indirectly (including through agents, contractors, trustees, representatives or advisors) (a) be in violation of any Sanctions
Law or engage in, or conspire or attempt to engage in, any transaction evading or avoiding any prohibition in any Sanction Law, (b) be
a Sanctioned Person or derive revenues from investments in, or transactions with Sanctioned Persons, (c) have any assets located
in Sanctioned Jurisdictions, (d) deal in, or otherwise engage in any transactions relating to, any property or interest in property
blocked pursuant to any Regulation administered or enforced by OFAC or (e) fail to comply with any material Regulations or Contractual
Obligations applicable to it or fail to obtain or comply with any material Permits; or

 

xi.            so
long as a majority of the original aggregate principal amount of the Notes remains outstanding on the date of any Variable Rate Transaction
the Company shall not directly or indirectly enter into a Variable Rate Transaction.

 

SECTION 5.     EVENTS
OF default

 

(a)            “Event
of Default” means, wherever used herein, any of the following events (whatever the reason for such event and whether such event
shall be voluntary or involuntary or effected by Regulation or pursuant to any judgment, decree or order of any court, or any order,
rule or Regulation of any Governmental Authority):

 

i.            any
default in the payment of (A) the principal amount of this Note or (B) interest, fees, liquidated damages or any other Obligation
owing to the Holder under this Note (or any other amount owing by the Company to the Holder under any other Contractual Obligation) or
any other amount owing by any Company Party under any Transaction Document, as and when the same shall become due and payable (whether
on a Conversion Date or the Maturity Date or by acceleration or otherwise) and such default is not cured, if possible to cure, within
five (5) Trading Days of such default;

 

ii.            any
Company Party shall fail for any reason to comply with Section 2.3 (Deliveries) of the Purchase Agreement, Section 4
(Negative Covenants) or Section 6(m) of this Note or any other Section of this Note or any Transaction Document
that provides for an action after a notice period or that provides a specific period of time for the Company Parties to comply with;

 

iii.            any
representation or warranty made by any Company Party in this Note, any other Transaction Document, any other Contractual Obligation with,
or any other report, financial statement, document, written statement or certificate made or delivered to, the Holder or any other Holder
shall be untrue or incorrect in any material respect as of the date when made or deemed made;

 

    	 	9	 

     

    

 

iv.            any
Company Party shall provide at any time notice to the Holder, including by way of public announcement, of such Company Party’s
intention to not honor any provision of this Note or any other Transaction Document (including requests for conversions of this Note
in accordance with the terms hereof);

 

v.            any
Company Party shall fail to observe or perform any other covenant, provision, or agreement contained in this Note or any other Transaction
Document which failure is not cured, if possible to cure, within the earlier to occur of (A) five (5) Trading Days after notice
of such failure sent by the Holder or by any other Holder to the Company and (B) ten (10) Trading Days after any Company Party
has become or should have become aware of such failure;

 

vi.           (a) a
breach, default or event of default (without regard for any cure period therefor provided therein) shall have occurred under any Indebtedness
of any Company Party (a) having (individually or in the aggregate for all such Indebtedness) an aggregate maximum principal amount
or commitment greater than One Hundred Thousand Dollars ($100,000), or (b) any such Indebtedness shall become or be declared due
and payable prior to the date on which it would otherwise become due and payable;

 

vii.          A
breach, default or event of default (without regard to any grace or cure period provided in the applicable agreement, document or instrument
or any subsequent waiver or other modification thereto) shall have occurred under any other Contractual Obligation to which any Company
Party is obligated;

 

viii.         (A) any
Company Party, any target under the Business Combination, or any Subsidiary (as such term is defined in Rule 1-02(w) of Regulation
S-X) of any Company Party commences a case or other Proceeding under any bankruptcy, reorganization, arrangement, adjustment of debt,
relief of debtors, dissolution, insolvency, winding up, reorganization, arrangement, adjustment, protection, relief or composition of
debts or liquidation or similar Regulation of any jurisdiction relating to the Company or any Subsidiary thereof or any Proceeding seeking
the entry of an order for relief or the appointment of a custodian, receiver, trustee, liquidator or other similar official for it or
for any of its assets, (B) any such case or other Proceeding is commenced against the Company, any target under the Business Combination,
or any Subsidiary thereof by any other Person and such case or other Proceeding is not dismissed within forty-five (45) days after commencement,
(C) the Company or any Subsidiary thereof is adjudicated insolvent or bankrupt or any order of relief or other order approving any
such case or other Proceeding is entered, (D) the Company or any Subsidiary thereof shall generally not pay its debts as such debts
become due, shall admit in writing its inability to pay its debts as they mature or shall make a general assignment for the benefit of
creditors, (E) the Company or any Subsidiary thereof calls a meeting of its creditors with a view to arranging a composition, adjustment
or restructuring of its debts or (F) the Company or any Subsidiary thereof, by any act or failure to act, expressly indicates its
consent to, approval of or acquiescence in any of the foregoing or takes any corporate or other action to authorize or otherwise for
the purpose of effecting any of the foregoing.

 

ix.            any
monetary judgment, writ or similar final process shall be entered or filed against any Company Party, any Subsidiary of any Company Party
or any of their assets for more than One Hundred Thousand Dollars ($100,000), and such judgment, writ or similar final process shall
remain unvacated, unbonded or unstayed for a period of thirty (30) calendar days;

 

x.             the
occurrence of any levy upon or seizure or attachment of, or any uninsured loss of or damage to, any asset of any Company Party or any
Subsidiary of any Company Party having an aggregate fair value or repair cost (as the case may be) in excess of One Hundred Thousand
Dollars ($100,000) individually or in the aggregate, and any such levy, seizure or attachment shall not be set aside, bonded or discharged
within thirty (30) days after the date thereof;

 

xi.            the
Company cancels or otherwise terminates the Business Combination Agreement anytime or fails to consummate the Business Combination on
or prior to December 15, 2022; or

 

xii.           the
Company sells or otherwise disposes of any of its assets outside of the ordinary course of its
business.

 

    	 	10	 

     

    

 

The clauses in
the definition of “Event of Default” above operate independently, so that any action or event that falls within any such
clause shall constitute an Event of Default regardless of, whether because of a grace period or threshold or otherwise, it falls outside
the language of any other clause.

 

(b)            Remedies
Upon Event of Default. If any Event of Default occurs, then the outstanding principal amount of this Note, plus accrued but unpaid
interest (including all interest, whether or not accruing after the filing of any petition in bankruptcy, or the commencement of any
insolvency, reorganization or similar proceeding, all of which shall continue to accrue whether or not a claim for post-filing or post-petition
interest is allowed in such proceeding), fees, liquidated damages and any other Obligations owing by any Company Party in respect thereof
or under any Transaction Document through the date of acceleration, shall become, at the Holder’s election in its sole discretion,
in whole or in part, (or, in the case of Section 7(a)(viii)(A) through (C), in whole, automatically and without the need for
any notice, demand or any other action by the Collateral Agent or the Holder all of which are hereby waived),immediately due and payable,
in cash, at the Mandatory Default Amount. Immediately on and after the occurrence of any Event of Default, without need for notice or
demand all of which are waived, interest on this Note shall accrue and be owed daily at an increased interest rate equal to the Default
Interest or the maximum rate permitted under applicable Regulations. Upon the payment in full of the Mandatory Default Amount in cash
or in shares of Common Stock, the Holder shall promptly surrender this Note to or as directed by the Company. In connection with such
acceleration described herein, the Holder need not provide, and the Company hereby waives, any presentment, demand, protest or other
notice of any kind (other than the Holder’s election to declare such acceleration), and the Holder may immediately and without
expiration of any grace period enforce any and all of its rights and remedies hereunder and all other remedies available to it under
applicable Regulations. Such acceleration may be rescinded and annulled by Holder at any time prior to payment hereunder and the Holder
shall have all rights as a holder of the Note until such time, if any, as the Holder receives full payment pursuant to this Section 5(b).
No such rescission or annulment shall affect any subsequent Event of Default or impair any right consequent thereon. The Company shall
provide all information and documentation to the Holder that is requested by the Holder to enable the Holder to confirm the Company’s
compliance with the terms and conditions of this Note and the other Transaction Documents and to enforce its rights hereunder and thereunder.

 

SECTION 6.     Miscellaneous

 

(a)            Notices.
Any and all notices or other communications or deliveries to be provided by the Holder hereunder shall be in writing and delivered as
set forth in the Purchase Agreement or, alternatively, delivered personally, by email or facsimile, or sent by a nationally recognized
overnight courier service, addressed to the Company as set forth in the signature pages hereof, or such other contact information
as the Company may specify for such purposes by notice to the Holder delivered in accordance with this Section 6(a). All
notices and other communications delivered hereunder shall be effective as provided in the Purchase Agreement.

 

(b)            Absolute
Obligation. Except as expressly provided herein, no provision of this Note shall alter or impair the obligation of the Company, which
is absolute and unconditional, to pay the principal of, liquidated damages and accrued interest, as applicable, on this Note, without
set off or counterclaim, at the time, place, and rate, and in the coin or currency, herein prescribed. This Note is a direct debt obligation
of the Company. This Note ranks pari passu with all other Notes now or hereafter issued under the terms set forth herein and is
at least pari passu with all Indebtedness and other obligations of the Company and is not subordinated to any such Indebtedness
or other obligation.

 

(c)            Lost
or Mutilated Note. If this Note shall be mutilated, lost, stolen or destroyed, the Company shall execute and deliver, in exchange
and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen or destroyed Note,
a new Note for the principal amount of this Note so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss,
theft or destruction of such Note, and of the ownership hereof, reasonably satisfactory to the Company.

 

(d)            Governing
Law. This Note is governed by, and shall be construed and enforced in accordance with, the laws of the State of Delaware.

 

    	 	11	 

     

    

 

(e)            Characterizations.
The Company covenants to the Holder that there shall be no characterization concerning this instrument other than as expressly provided
herein. Amounts set forth or provided for herein with respect to payments and the like (and the computation thereof) shall be the amounts
to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or
the performance thereof).S

 

(f)             Payments
on Next Business Day. Whenever any payment Obligation shall be due on a day other than a Business Day, such payment shall be due
instead on the next succeeding Business Day.

 

(g)            Payment
of Collection, Enforcement and Other Costs. In addition to, and not in substitution for and not to limit (but without duplication),
any other right to reimbursement under this Note or any other Transaction Document, (i) this Note is placed in the hands of an attorney
for collection or enforcement or is collected or enforced through any Proceeding or the Holder otherwise takes action to collect amounts
due under this Note or to enforce the provisions of this Note or (ii) there occurs any bankruptcy, reorganization, receivership
of the Company or other Proceedings affecting Company creditors’ rights and involving a claim under this Note, then the Company
shall pay all out-of-pocket costs incurred by the Holder for such collection, enforcement or action or in connection with such bankruptcy,
reorganization, receivership or other Proceeding, including, but not limited to, attorneys’ fees and disbursements.

 

(h)            Security
Interest. The Obligations of the Company Parties under this Note and the other Transaction Documents are secured by the Security
Agreement and the Intellectual Property Security Agreement, as well as other Transaction Documents.

 

(i)             Use
of Proceeds. All gross proceeds of the funding to the Company related to this Note shall be used as provided in the Purchase Agreement.

 

(j)             Securities
Laws Disclosure; Publicity. If applicable, the Company shall file a Current Report on Form 8-K, including the Transaction Documents
as exhibits thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such Current Report
on Form 8-K, the Company represents to the Holder that it shall have publicly disclosed all material, non-public information delivered
to any of the Holder by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in
connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such Current
Report on Form 8-K, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement,
whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees
or Affiliates on the one hand, and the Holder or any of its Affiliates on the other hand, shall terminate. Notwithstanding the foregoing,
the Company shall not publicly disclose the name of the Holder, or include the name of the Holder in any filing with the Commission or
any regulatory agency or Trading Market, without the prior written consent of the Holder, except (i) as required by federal securities
Regulation in connection with the filing of final Transaction Documents with the Commission and (ii) to the extent such disclosure
is required by Regulations (including Trading Market regulations), in which case the Company shall provide the Holder with prior notice
of such disclosure permitted under this clause (ii).

 

(k)            Non-Public
Information. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which, if applicable, shall be disclosed pursuant to Section 6(j), the Company covenants and agrees that neither it, nor
any other Person acting on its behalf has provided nor will provide the Holder or its agents or counsel with any information that constitutes,
or the Company reasonably believes constitutes, material non-public information, unless prior thereto the Holder shall have consented
to the receipt of such information and agreed with the Company to keep such information confidential. The Company understands and confirms
that the Holder will be relying on the foregoing covenant in effecting transactions in Securities of the Company. Any non-disclosure
agreement (including “click through” agreements and confidentiality clauses incorporated in larger agreements) entered into
with the Holder and any Company Party is hereby terminated. The Holder does not have any duty of confidentiality (or a duty not to trade
on the basis of material non-public information) to any Company Party or any of their Affiliates, or any of their respective officers,
directors, agents, members, stockholders, managers, employees and is governed only by application Regulations. To the extent that any
notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company
or any Subsidiaries, the Company, as applicable, shall, within two (2) Trading Days, file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Company understands and confirms that the Holder shall be relying on all of the foregoing covenants
in trading Securities of the Company.

 

    	 	12	 

     

    

 

(l)               Interpretation.
This Note is a Transaction Document and as such is subject to various interpretative, amendment and third party beneficiary and other
miscellaneous provisions set forth in the Purchase Agreement that expressly apply to Transaction Documents, located principally in Article VI
thereof. In particular, without limitation, none of the terms or provisions of this Note may be waived, amended, supplemented or
otherwise modified except in accordance with Section 6.3(b) (Amendments) of the Purchase Agreement.

 

(m)           Successors
and Assigns. This Note shall be binding upon the successors and assigns of the Company and shall inure to the benefit of the Holder,
each Purchaser Party and their successors and assigns; provided, that the Company may not assign, transfer or delegate any of
its rights or obligations under this Note except as authorized in the Purchase Agreement.

 

(n)            Counterparts.
This Note may be executed in any number of counterparts and by different parties in separate counterparts, each of which when so executed
shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Signature pages may
be detached from multiple separate counterparts and attached to a single counterpart. Delivery of an executed signature page of
this Note by facsimile transmission or by e-mail shall be as effective as delivery of a manually executed counterpart hereof.

 

(o)            Severability.
Any provision of this Note being held illegal, invalid or unenforceable in any jurisdiction shall not affect any part of such provision
not held illegal, invalid or unenforceable, any other provision of this Note or any part of such provision in any other jurisdiction.

 

(p)            Waiver
of Jury Trial. Each party hereto hereby irrevocably waives trial by jury in any Proceeding with respect to, or directly or indirectly
arising out of, under or in connection with, this Note or any other Transaction Document or the transactions contemplated therein or
related thereto (whether founded in contract, tort or any other theory). Each party hereto (A) certifies that no other party,
no Purchaser Party and no Affiliate or representative of any such other party or Affiliate has represented, expressly or otherwise, that
such other party would not, in the event of litigation, seek to enforce the foregoing waiver and (B) acknowledges that it and the
other parties hereto have been induced to enter into this Note by the mutual waivers and certifications in this Section 6(p).

 

[Signature
Page Follows]

 

    	 	13	 

     

    

 

IN
WITNESS WHEREOF, Company has caused this Senior Secured Promissory Note to be duly executed by a duly authorized officer as of the date
first above indicated.

 

	 	 

 

	 	By:	 
	 	 	Name:
	 	 	Title:

 

	 	Address:
	 	 
	 	Email Address for delivery
of Notices:

 

    14Exhibit 10.9

 

EXECUTION COPY

 

WARRANT NO. [___]

 

NONE OF THIS SECURITY OR THE SECURITIES INTO
WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY
STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
AND, ACCORDINGLY, NONE OF THEM MAY BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT,
THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS
SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

WARRANT TO PURCHASE SHARES OF COMMON STOCK

of

DIGITAL
HEALTH ACQUISITION CORP.

 

This certifies that, for
value received, _________________________ or its assignees (the “Holder”) is entitled, subject to the terms set forth below,
to purchase from Digital Health Acquisition Corp., a Delaware corporation (the “Company”), 173,913 shares of Common
Stock of the Company, $0.0001 par value per share (the “Warrant Shares”), as constituted on the date hereof (the “Warrant
Issue Date”), upon surrender hereof, at the principal office of the Company referred to below, with the subscription form attached
hereto duly executed, and simultaneous payment therefor in lawful money of the United States or otherwise as hereinafter provided, at
the exercise price as set forth in Section 2 below (the “Exercise Price”). The number, character and Exercise
Price of the Warrant Shares is subject to adjustment as provided below. The term “Warrant” as used herein shall include this
Warrant and any warrants delivered in substitution or exchange therefor as provided herein.

 

This Warrant is issued pursuant
to that certain Securities Purchase Agreement (the “Purchase Agreement”) among the Company, VSee Lab, Inc., a
Delaware corporation (“VSee”) and iDoc Virtual Telehealth Solutions, Inc., a Texas corporation (“iDoc”)
and Holder and the other holders listed therein dated October 5, 2022 and represents the date on which full consideration for the
issuance of this Warrant passed. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in the Purchase
Agreement.

 

1.             Term
of Warrant. The purchase right represented by this Warrant shall terminate on or before 5:30 p.m., Pacific Time, on the date five
years from the date of this Warrant (the “Expiration Date”).

 

2.             Exercise
Price. The Exercise Price at which this Warrant may be exercised shall be $11.50 per share of Common Stock, as adjusted from time
to time pursuant to Section 10 hereof.

 

3.             Exercise
of Warrant.

 

3.1           Exercise
Form. In order to exercise this Purchase Warrant, the exercise form attached hereto must be duly executed and completed and delivered
to the Company or the Company’s Transfer Agent, together with this Purchase Warrant and payment of the Exercise Price for the Shares
being purchased payable in cash by wire transfer of immediately available funds to an account designated by the Company or by certified
check or official bank check. If the rights represented hereby shall not be exercised at or before 5:00 p.m., New York time, on the Expiration
Date, this Purchase Warrant shall become and be void without further force or effect, and all rights represented hereby shall cease and
expire.

 

     

     

    

 

3.2           Cashless
Exercise.  If at any time after the date of this Warrant there is no effective registration statement registering, or no current
prospectus available for, the resale of the Shares by the Holder, then in lieu of exercising this Purchase Warrant by payment of cash
or check payable to the order of the Company pursuant to Section 3.1 above, Holder may elect to receive the number of Shares equal
to the value of this Purchase Warrant (or the portion thereof being exercised), by surrender of this Purchase Warrant to the Company
or the Company’s Transfer Agent, together with the exercise form attached hereto, in which event the issue to Holder, Shares in
accordance with the following formula:

 

	X	=	Y(A-B)	 
	A	 
	Where,	X	=	The
    number of Shares to be issued to Holder;
	 	Y	=	The
    number of Shares for which the Purchase Warrant is being exercised;
	 	A	=	The
    fair market value of one Share; and
	 	B	=	The
    Exercise Price.
	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 

For purposes of this Section 3.2, the fair
market value of a Share is defined as follows:

 

(i)            if
the Company’s common stock is traded on a securities exchange, the value shall be deemed to be the closing price on such exchange
prior to the exercise form being submitted in connection with the exercise of the Purchase Warrant; or

 

(ii)           if
the Company’s common stock is actively traded over-the-counter, the value shall be deemed to be the closing price on such exchange
prior to the exercise form being submitted in connection with the exercise of the Purchase Warrant; or

 

(iii)          if
there is no active public market, the value shall be the fair market value thereof, as determined in good faith by the Company’s
Board of Directors.

 

4.             No
Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall make a cash payment equal
to the Exercise Price multiplied by such fraction.

 

5.             Replacement
of Warrant. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant
and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and substance to
the Company or, in the case of mutilation, on surrender and cancellation of this Warrant, the Company at its expense shall execute and
deliver, in lieu of this Warrant, a new warrant of like tenor and amount.

 

6.             Rights
of Shareholders. Except as otherwise provided herein, this Warrant shall not entitle its Holder to any of the rights of a shareholder
of the Company.

 

		7.	Transfer of Warrant.

 

(a)            Restrictions
on transfer of Warrant. Subject to compliance with any applicable securities laws and the provisions of Section 4.1 of the Purchase
Agreement, Holder may transfer or assign this Warrant in whole or in part

 

     

     

    

 

(b)            Exchange
of Warrant Upon a Transfer. On surrender of this Warrant for exchange and subject to the provisions of this Warrant with respect to compliance
with the limitations on transfers contained in this Section 7, the Company at its expense shall issue to or on the order of the
Holder a new warrant or warrants of like tenor, in such names as the Holder may direct, for the number of shares issuable upon exercise
hereof.

 

8.            Reservation
of Stock. The Company covenants that during the term this Warrant is exercisable, the Company will reserve from its authorized and
unissued Common Stock a sufficient number of shares to provide for the issuance of Common Stock upon the exercise of this Warrant and,
from time to time, will take all steps necessary to amend its Certificate of Incorporation (the “Charter”) to provide
sufficient reserves of shares of Common Stock issuable upon exercise of the Warrant. The Company further covenants that all shares that
may be issued upon the exercise of rights represented by this Warrant and payment of the Exercise Price, all as set forth herein, will
be free from all taxes, liens and charges in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously
or otherwise specified herein). The Company agrees that its issuance of this Warrant shall constitute full authority to its officers
who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for shares of Common Stock
upon the exercise of this Warrant, and that such certificates shall be issued in the names of, or in such names as may be directed by,
the Holder.

 

9.             Notices.

 

(a)            Whenever
the Exercise Price or number of shares purchasable hereunder shall be adjusted pursuant to Section 10 hereof, the Company shall
issue a certificate signed by its Chief Financial Officer or President, setting forth, in reasonable detail, the event requiring the
adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Exercise Price and number of shares
purchasable hereunder after giving effect to such adjustment, and shall cause a copy of such certificate to be delivered to the Holder
of this Warrant.

 

		(b)	In case:

 

(i)            the
Company shall take a record of the holders of its Common Stock (or other stock or securities at the time receivable upon the exercise
of this Warrant) for the purpose of entitling them to receive any dividend or other distribution, or any right to subscribe for or purchase
any shares of stock of any class or any other securities, or to receive any other right, or

 

(ii)           of
any capital reorganization of the Company, any reclassification of the capital stock of the Company, any consolidation or merger of the
Company with or into another corporation, or any conveyance of all or substantially all of the assets of the Company to another corporation,
or

 

(iii)          of
any voluntary dissolution, liquidation or winding-up of the Company,

 

then, and in each such case, the Company will
deliver or cause to be delivered to the Holder or Holders a notice specifying, as the case may be, (A) the date on which a record
is to be taken for the purpose of such dividend, distribution or right, and stating the amount and character of such dividend, distribution
or right, or (B) the date on which such reorganization, reclassification, consolidation, merger, conveyance, dissolution, liquidation
or winding-up is to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock (or such other
stock or securities at the time receivable upon the exercise of this Warrant) shall be entitled to exchange their shares of Common Stock
(or such other stock or securities) for securities or other property deliverable upon such reorganization, reclassification, consolidation,
merger, conveyance, dissolution, liquidation or winding-up. Such notice shall be delivered at least 15 days prior to the date therein
specified.

 

10.           Adjustments.
Prior to the Expiration Date, the Exercise Price and the number of Warrant Shares purchasable upon the exercise of each Warrant are subject
to adjustment from time to time upon the occurrence of any of the events enumerated in this Section 10.

 

     

     

    

 

(a)            In
the event that the Company shall at any time after the date of this Warrant (i) declare a dividend on Common Stock in shares or
other securities of the Company, (ii) split or subdivide the outstanding Common Stock, (iii) combine the outstanding Common
Stock into a smaller number of shares, or (iv) issue by reclassification of its Common Stock any shares or other securities of the
Company, then, in each such event, the Exercise Price in effect at the time shall be adjusted so that the holder shall be entitled to
receive the kind and number of such shares or other securities of the Company which the holder would have owned or have been entitled
to receive after the happening of any of the events described above had such Warrant been exercised immediately prior to the happening
of such event (or any record date with respect thereto). Such adjustment shall be made whenever any of the events listed above shall
occur. An adjustment made pursuant to this paragraph (a) shall become effective immediately after the effective date of the event
retroactive to the record date, if any, for the event.

 

(b)            No
adjustment in the number of Warrant Shares shall be required unless such adjustment would require an increase or decrease of at least
0.1% in the aggregate number of Warrant Shares purchasable upon exercise of all Warrants; provided that any adjustments which
by reason of this Section 10(b) are not required to be made shall be carried forward and taken into account in any subsequent
adjustment; provided, however, that notwithstanding the foregoing, all such adjustments shall be made no later than three years
from the date of the first event that would have required an adjustment but for this paragraph. All calculations under this Section 10
shall be made to the nearest cent or to the nearest hundredth of a share, as the case may be.

 

(c)            If
at any time, as a result of an adjustment made pursuant to this Section 10, the holder of any Warrant thereafter exercised shall
become entitled to receive any shares of the Company other than shares of Common Stock, thereafter the number of such other shares so
receivable upon exercise of any Warrant shall be subject to adjustment from time to time in a manner and on terms as nearly equivalent
as practicable to the provisions with respect to the Warrant Shares contained in this Section 10, and the provisions of this Warrant
with respect to the Warrant Shares shall apply on like terms to such other shares.

 

(d)            Whenever
the Exercise Price payable upon exercise of each Warrant is adjusted pursuant to this Section 10, the Warrant Shares shall be adjusted
by multiplying the number of Warrant Shares immediately prior to such adjustment by a fraction, the numerator of which shall be the Exercise
Price in effect immediately prior to such adjustment, and the denominator of which shall be the Exercise Price as adjusted.

 

(e)            In
the event of any capital reorganization of the Company, or of any reclassification of the Common Stock (other than a reclassification
referred to in paragraph (a) (iv) above), or in case of the consolidation of the Company with or the merger of the Company
with or into any other corporation or of the sale the properties and assets of the Company as, or substantially as, an entirety to any
other corporation, each Warrant shall, after such capital reorganization, reclassification of Common Stock, consolidation, merger or
sale, and in lieu of being exercisable for Warrant Shares, be exercisable, upon the terms and conditions specified in this Warrant, for
the number of shares of stock or other securities or assets to which holder of the number of Warrant Shares purchasable upon exercisable
of such Warrant immediately prior to such capital organization, reclassification of Common Stock, consolidation, merger or sale would
have been entitled upon such capital organization, reclassification of Common Stock, consolidation, merger or sale; and in any such case,
if necessary, the provisions set forth in this Section 10 with respect to the rights thereafter of the holders of the Warrants shall
be appropriately adjusted so as to be applicable, as nearly as they may reasonably be, to any shares of stock or other securities or
assets thereafter deliverable on the exercise of the Warrants. The Company shall not effect any such consolidation, merger or sale, unless
prior to or simultaneously with the consummation thereof, the successor corporation (if other than the Company) resulting from such consolidation
or merger or the corporation purchasing such assets or the appropriate corporation or entity shall assume, by written instrument, the
obligation to deliver to holder of each Warrant the shares of stock, securities or assets to which, in accordance with the foregoing
provisions, such holder may be entitled and all other obligations of the Company under this Warrant. The provisions of this paragraph
(f) shall apply to successive reorganizations, reclassification, consolidations, mergers and sales.

 

(f)            Irrespective
of any adjustments in the Exercise Price or the number or kind of shares purchasable upon exercise of the Warrants, Warrant Certificates
theretofore or thereafter issued may continue to express the same Exercise Price per share and number and kind of shares as are stated
on the Warrant Certificates initially issuable pursuant to this Warrant.

 

     

     

    

 

(g)            In
addition to and not in limitation of the other provisions of this Section 10, if the Company in any manner issues or sells or enters
into any agreement to issue or sell, any Common Stock, options or convertible securities (any such securities, “Variable Price
Securities”) after the Warrant Issue Date that are issuable pursuant to such agreement or convertible into or exchangeable
or exercisable for shares of Common Stock at a price which varies or may vary with the market price of the shares of Common Stock, including
by way of one or more reset(s) to a fixed price, but exclusive of such formulations reflecting customary anti-dilution provisions
(such as share splits, share combinations, share dividends and similar transactions) (each of the formulations for such variable price
being herein referred to as, the “Variable Price”), the Company shall provide written notice thereof via facsimile
and overnight courier to the Holder on the date of such agreement and the issuance of such convertible securities or options. From and
after the date the Company enters into such agreement or issues any such Variable Price Securities, the Holder shall have the right,
but not the obligation, in its sole discretion to substitute the Variable Price for the Exercise Price upon exercise of this Warrant
by designating in the exercise form delivered upon any exercise of this Warrant that solely for purposes of such exercise the Holder
is relying on the Variable Price rather than the Exercise Price then in effect. The Holder’s election to rely on a Variable Price
for a particular exercise of this Warrant shall not obligate the Holder to rely on a Variable Price for any future exercises of this
Warrant.

 

(h)            In
case any event shall occur as to which the other provisions of this Section 10 are not strictly applicable or the failure to make
any adjustment would result in an unfair enlargement or dilution of the purchase rights represented by the Warrants in accordance with
the essential intent and principles hereof, then, in each such case, the independent auditors of the Company shall give its opinion as
to the adjustment, if any, on a basis consistent with the essential intent and principles established in this Section 11, necessary
to preserve, without enlargement or dilution, the purchase rights presented by the Warrants. Upon receipt of such opinion, the Company
shall promptly mail a copy thereof to the registered holders of the Warrants and shall make the adjustment described therein.

 

(i)            [Reserved].

 

		11.	Miscellaneous.

 

(a)            Unless
otherwise provided, any notice required or permitted hereunder shall be given by personal service upon the party to be notified by certified
mail, return receipt requested and: (i) if to the Company, addressed to  _________________________, [address of the institutional investor], or at such other address as the Company may designate by notice to each of the Investors in accordance with the provisions
of this Section; and (ii) if to the Warrant holder, at the address indicated as such Holder may designate by notice to the Company
in accordance with the provisions of this Section.

 

(b)            The
Company and Holder shall each execute and deliver all such further instruments, documents and papers, and shall perform any and all acts
necessary, to give full force and effect to all of the terms and provisions of this Warrant.

 

(c)            This
Warrant shall inure to the benefit of and be binding upon the parties hereto, and their successors in interest.

 

(d)            This
Warrant incorporates the entire understanding of the parties and supersedes all previous agreements relating to the subject matter hereof
should they exist. This Warrant and any issue arising out of or relating to the parties’ relationship hereunder shall be governed
by, and construed in accordance with, the laws of the State of Delaware, without regard to principles of conflicts of law. In all matters
of interpretation, whenever necessary to give effect to any provision of this Warrant, each gender shall include the others, the singular
shall include the plural, and the plural shall include the singular. The titles of the paragraphs of this Warrant are for convenience
only and shall not in any way affect the interpretation of any provision or condition of this Warrant.

 

(e)            In
the event of any litigation or arbitration between the parties hereto respecting or arising out of this Warrant, the prevailing party
shall be entitled to recover reasonable legal fees, whether or not such litigation or arbitration proceeds to final judgment or determination.

 

     

     

    

 

(f)            Jurisdiction
and Venue. Each party hereto consents specifically to the exclusive jurisdiction of the federal courts of the United States sitting in
Delaware, or if such federal court declines to exercise jurisdiction over any action filed pursuant to this Warrant, the courts of the
State of Delaware and any court to which an appeal may be taken in connection with any action filed pursuant to this Warrant, for the
purposes of all legal proceedings arising out of or relating to this Warrant. In connection with the foregoing consent, each party irrevocably
waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the court's exercise of personal
jurisdiction over each party to this Warrant or the laying of venue of any such proceeding brought in such a court and any claim that
any such proceeding brought in such a court has been brought in an inconvenient forum. Each party further irrevocably waives its right
to a trial by jury and consents that service of process may be effected in any manner permitted under the laws of the State of Delaware.

 

(g)            If
any clause or provision of this Warrant is illegal, invalid or unenforceable under present or future laws effective during the term of
this Warrant, then and, in that event, the remainder of this Warrant shall not be affected thereby, and in lieu of each clause or provision
of this Warrant that is illegal, invalid or unenforceable, there shall be added a clause or provision as similar in terms and in amount
to such illegal, invalid or unenforceable clause or provision as may be possible and be legal, valid and enforceable, as long as it does
not otherwise frustrate the principal purposes of this Warrant.

 

     

     

    

 

IN WITNESS WHEREOF, Digital
Health Acquisition Corp. has caused this Warrant to be executed by its officers thereunto duly authorized.

 

Dated:     October 5,
2022

 

	 	DIGITAL HEALTH ACQUISITION CORP.
	 	 
	 	By:	 
	 	 	Name:
	 	 	Its:

 

     

     

    

 

EXHIBIT A

NOTICE OF EXERCISE

(To be signed only upon exercise of the Warrant)

 

NOTICE OF EXERCISE

 

To:     __________________________

 

The undersigned hereby elects to purchase ________
Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment
of the exercise price in full, together with all applicable transfer taxes, if any.

 

(1)
Payment shall take the form of (check applicable box):

 

[  ] in lawful money of the United
States; or

 

[ ] if permitted the cancellation of
such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 3.2, to exercise this Warrant with
respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 3.2.

 

(2)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

_______________________________

 

The Warrant Shares shall be delivered to the following
DWAC Account Number:

 

_______________________________

 

_______________________________

 

_______________________________

 

(3)
Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under
the Securities Act of 1933, as amended.

 

[SIGNATURE OF HOLDER]

 

	Name of Investing Entity:	

Signature
of Authorized Signatory of Investing Entity:

		 

Name of Authorized Signatory:

		 

Title of Authorized Signatory:

		 

Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}]]